TANDEM

WIPO WIPO 2012

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke TANDEM wurde als Wortmarke am 07.12.2012 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 24. Februar 2023

Markenform Wortmarke
Aktenzeichen 1156119
Länder Australien Schweiz China Kolumbien Kuba Europäische Gemeinschaft Japan
Anmeldedatum 07. Dezember 2012
Ablaufdatum 24. August 2015

Markeninhaber

Clarendon House,
2 Church Street,
GB

Markenvertreter

1055 Thomas Jefferson St. NW, Suite 400 Washington DC 20007 US

Waren und Dienstleistungen

10 Medical devices; medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; drug delivery device, namely a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; drug delivery device, namely a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
26. Februar 2016 2016/19 Gaz US RAW: Total Ceasing Effect
16. April 2015 2015/25 Gaz CO RAW: Rule 18ter(2)(i) GP following a provisional refusal
27. November 2014 2014/48 Gaz JP Ablehnung
15. April 2014 2014/20 Gaz CH Ablehnung
17. März 2014 2014/12 Gaz CU Ablehnung
03. März 2014 2014/19 Gaz RAW: Limitation
27. Februar 2014 2014/9 Gaz EM Ablehnung
30. Januar 2014 2014/5 Gaz JP Ablehnung
07. Januar 2014 2014/5 Gaz CN Ablehnung
29. Oktober 2013 2013/44 Gaz CO Ablehnung
28. Mai 2013 2013/24 Gaz US Korrektur
06. Mai 2013 2013/19 Gaz AU Ablehnung
07. Dezember 2012 2013/15 Gaz US Eintragung

ID: 141156119